Literature DB >> 11800249

New advances in the management of acute coronary syndromes: 3. The role of catheter-based procedures.

Christopher E Buller1, Ronald G Carere.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11800249      PMCID： PMC99227     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  31 in total

1.  Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.

Authors:  A M Lincoff; R M Califf; D J Moliterno; S G Ellis; J Ducas; J H Kramer; N S Kleiman; E A Cohen; J E Booth; S K Sapp; C F Cabot; E J Topol
Journal:  N Engl J Med       Date:  1999-07-29       Impact factor: 91.245

2.  Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2000-12-16       Impact factor: 79.321

3.  New advances in the management of acute coronary syndromes: 1. Matching treatment to risk.

Authors:  D Fitchett; S Goodman; A Langer
Journal:  CMAJ       Date:  2001-05-01       Impact factor: 8.262

4.  Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.

Authors:  A Schömig; A Kastrati; J Dirschinger; J Mehilli; U Schricke; J Pache; S Martinoff; F J Neumann; M Schwaiger
Journal:  N Engl J Med       Date:  2000-08-10       Impact factor: 91.245

5.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

6.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

Authors:  L Wallentin; B Lagerqvist; S Husted; F Kontny; E Ståhle; E Swahn
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

7.  Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial.

Authors:  W D Weaver; M A Reisman; J J Griffin; C E Buller; P P Leimgruber; T Henry; C D'Haem; V L Clark; J S Martin; D J Cohen; N Neil; N R Every
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

8.  Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA).

Authors:  C E Buller; V Dzavik; R G Carere; G B Mancini; G Barbeau; C Lazzam; T J Anderson; M L Knudtson; J F Marquis; T Suzuki; E A Cohen; R S Fox; K K Teo
Journal:  Circulation       Date:  1999-07-20       Impact factor: 29.690

9.  Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group.

Authors:  C L Grines; D A Cox; G W Stone; E Garcia; L A Mattos; A Giambartolomei; B R Brodie; O Madonna; M Eijgelshoven; A J Lansky; W W O'Neill; M C Morice
Journal:  N Engl J Med       Date:  1999-12-23       Impact factor: 91.245

10.  One-year survival following early revascularization for cardiogenic shock.

Authors:  J S Hochman; L A Sleeper; H D White; V Dzavik; S C Wong; V Menon; J G Webb; R Steingart; M H Picard; M A Menegus; J Boland; T Sanborn; C E Buller; S Modur; R Forman; P Desvigne-Nickens; A K Jacobs; J N Slater; T H LeJemtel
Journal:  JAMA       Date:  2001-01-10       Impact factor: 56.272
View more
  3 in total

Review 1.  Rising to the challenge: transforming the treatment of ST-segment elevation myocardial infarction.

Authors:  William A Ghali; Cameron R Donaldson; Merril L Knudtson; Steven J Lewis; Colleen J Maxwell; Jack V Tu
Journal:  CMAJ       Date:  2003-07-08       Impact factor: 8.262

Review 2.  Primary angioplasty for ST-segment elevation myocardial infarction: ready for prime time?

Authors:  Madhu K Natarajan; Salim Yusuf
Journal:  CMAJ       Date:  2003-07-08       Impact factor: 8.262

3.  CYPHER coronary stents and risk of thrombosis.

Authors:  Stephen B Choi
Journal:  CMAJ       Date:  2003-08-05       Impact factor: 8.262
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.